miR-199a-3p suppresses Vldlr expression to promote cardiomyocyte proliferation

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Regenerative Medicine

Background:

• Cardiomyocyte proliferation is limited in adult mammals, hindering tissue repair after ischemic injury.
• MicroRNA-199a-3p (miR-199a-3p) is known to promote cardiomyocyte proliferation, but its precise mechanism is not fully understood.
• Very-low-density-lipoprotein receptor (Vldlr) has been identified as an inhibitor of cardiomyocyte proliferation.

Purpose of the Study:

• To investigate whether Vldlr is a functional target of miR-199a-3p.
• To elucidate the molecular mechanism by which miR-199a-3p regulates cardiomyocyte proliferation.
• To explore the potential of the miR-199a-3p-Vldlr-RB1 axis as a therapeutic target for cardiac regeneration.

Main Methods:

• 3'UTR reporter assays to confirm direct binding of miR-199a-3p to Vldlr mRNA.
• Overexpression of Vldlr in cardiomyocytes to assess its impact on miR-199a-3p's pro-proliferative effects.
• Analysis of RB1 phosphorylation (S807/811) and inhibition of CDK4/6 to determine the role of RB1 in the proliferation pathway.

Main Results:

• miR-199a-3p directly binds to the 3'UTR of Vldlr and inhibits its translation.
• Overexpression of Vldlr counteracted the pro-proliferative effect of miR-199a-3p in cardiomyocytes.
• Vldlr was found to reduce RB1 S807/811 phosphorylation; inhibiting CDK4/6 blocked proliferation induced by Vldlr knockdown or miR-199a-3p overexpression, indicating RB1 phosphorylation is essential.

Conclusions:

• Vldlr is a novel functional target of miR-199a-3p in cardiomyocytes.
• RB1 phosphorylation is a critical downstream effector in the miR-199a-3p-mediated cardiomyocyte proliferation pathway.
• The miR-199a-3p-Vldlr-RB1 axis presents a promising target for therapeutic strategies in cardiac regenerative medicine.